The rising efforts by the pharmaceutical manufacturers and drug developers across the world on development of novel therapies aimed at treating various infectious diseases is one of the strongest motivators for the growth in the global antibiotics market in coming years. Furthermore, rising prevalence of various infectious diseases, such as pneumonia, tuberculosis, lower respiratory infections, and malaria is also driving the growth in the global antibiotics market. The resulting rise in the disease burden is motivating non-government as well as government authorities to fund research and development initiatives in order to fast track the development of novel antibiotic drugs and therapies.
The corporate survey report offers a comprehensive assessment of the contemporary trends that may impact the development of global antibiotics market over the forecast period i.e. 2021 to 2031. The report records the trajectory of global antibiotics market through base years and historic years to predict the performance of the sector till 2031. The business intelligence report takes a closer look at various segments in global antibiotics market and assesses these segments based on their status, size, share, revenue, and forecast to 2031. It also informs the readers about key driving as well as the restraining factors faced by the participants in the global antibiotics market.
The increase in the supportive government legislation pertaining to pharmaceutical production as well as the increasing prevalence of infectious diseases are two of the most significant drivers for the development of the global antibiotics market. Some other major driving factors propelling growth within the global antibiotics market include rise in the antibiotic resistance infections owing to the overuse or misuse of antibiotic drugs, resultant shift in prescription patterns to treat these bacterial infections through the usage of novel therapies, and rising global elderly population. Supportive legislative policies by governments across the world are also likely to aid in the expansion of the global antibiotics market in coming years.
Some of the most notable players functional within the global antibiotics market are Allergen PLC, Pfizer, Inc., Basilea Pharmaceutica Ltd., Paratek Pharmaceuticals, Inc., Spero Therapeutics, Merck & Co., Inc., GlaxoSmithKline PLC, Melinta Therapeutics, Tetraphase Pharmaceuticals, and Nabriva Therapeutics, PLC, among others. The manufacturers and players operational within the global antibiotics market are adopting several corporate development strategies, most notably mergers and acquisitions as well as strategic collaborations to diversify their product portfolios.
For example, Basilea Pharmaceutica Ltd. And Forge Therapeutics recently collaborated in order to research and develop novel antibiotic treatment therapies. Similarly, Evotec AG and Nosopharm also collaborated recently in order to develop a novel antibiotic known as NOSO-502. These strategic collaborations are expected to benefit the global antibiotics market in coming years by providing consumers with new and more effective treatment solutions.
In recent past, Asia Pacific region held the most significant share in terms of revenue within the global antibiotics market. This high portion of the industry revenue in the global antibiotics market was attributed to Asia Pacific owing to several factors, such as the rise in the consumption of antibiotics by the regional population, increase in the government initiatives aimed at promoting the development of novel treatment therapeutics, and increasing prevalence of various infectious diseases in the region. Furthermore, unregulated sales in regional economies such as China and India as well as the massive presence of numerous generic players are also fuelling the demand within the global antibiotics market in Asia Pacific region in near future.
Another region expected to perform admirably in the global antibiotics market in coming years is North America. This trend can be attributed to highly regulated nature of the healthcare industry in the region as well as the presence of well-established and technologically potent healthcare and medical infrastructure in the region.
Interested in this report?
Get a FREE Brochure now!
*Get Brochure (PDF) sent to your email within minutes
Complete the form below and we'll get back to you shortly.